May C. Morris

7.9k total citations · 2 hit papers
104 papers, 6.3k citations indexed

About

May C. Morris is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, May C. Morris has authored 104 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 25 papers in Oncology and 20 papers in Cell Biology. Recurrent topics in May C. Morris's work include Advanced biosensing and bioanalysis techniques (34 papers), RNA Interference and Gene Delivery (30 papers) and Cancer-related Molecular Pathways (24 papers). May C. Morris is often cited by papers focused on Advanced biosensing and bioanalysis techniques (34 papers), RNA Interference and Gene Delivery (30 papers) and Cancer-related Molecular Pathways (24 papers). May C. Morris collaborates with scholars based in France, United States and Spain. May C. Morris's co-authors include Gilles Divita, F. Heitz, Sébastien Deshayes, Jean Méry, Julien Depollier, Morgan Pellerano, Gudrun Aldrian, Camille Prével, Marion Peyressatre and Laurent Chaloin and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

May C. Morris

95 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A peptide carrier for the delivery of biologically active proteins into mammalian cells

2001 851 citations May C. Morris, F. Heitz et al. profile →
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics

2009 713 citations F. Heitz, May C. Morris et al. British Journal of Pharmacology profile →

Peers

Countries citing papers authored by May C. Morris

Since Specialization

Citations

This map shows the geographic impact of May C. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May C. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May C. Morris more than expected).

Fields of papers citing papers by May C. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May C. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May C. Morris. The network helps show where May C. Morris may publish in the future.

Co-authorship network of co-authors of May C. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of May C. Morris. A scholar is included among the top collaborators of May C. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May C. Morris. May C. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells 2022 ·The Journal of Cell Biology ·Rebecca Harris, Ming Yang, Christina Schmidt, (unknown), Sarbjit Singh, Amarnath Natarajan, May C. Morris, Christian Frezza, Heike Laman	11
2	Nanobiosensor Reports on CDK1 Kinase Activity in Tumor Xenografts in Mice 2021 ·Small ·Carmen Tîlmaciu, Bhimareddy Dinesh, Morgan Pellerano, (unknown), (unknown), Julien Vollaire, Alberto Bianco, Cécilia Ménard‐Moyon, Véronique Josserand, May C. Morris	7
3	Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth 2020 ·Theranostics ·Céline Bouclier, Matthieu Simon, Guillaume Laconde, Morgan Pellerano, (unknown), Sylvie Lantuéjoul, Benoît Busser, Laetitia Vanwonterghem, Julien Vollaire, Véronique Josserand, Baptiste Legrand, Jean‐Luc Coll, Muriel Amblard, Amandine Hurbin, May C. Morris	16
4	Microneedle Array‐Based Platforms for Future Theranostic Applications 2019 ·ChemBioChem ·Olivia Howells, (unknown), Sarah McIntyre, (unknown), (unknown), Yufei Liu, Owen James Guy, Anthony E. G. Cass, May C. Morris, Sanjiv Sharma	16
5	230 Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity 2019 ·Journal of Investigative Dermatology ·(unknown), Camille Prével, Morgan Pellerano, (unknown), P Stoebner, May C. Morris, L. Meunier	3
6	Lanthanide-based peptide biosensor to monitor CDK4/cyclin D kinase activity 2017 ·Chemical Communications ·Juan A. González‐Vera, (unknown), Céline Bouclier, M. Eugenio Vázquez, May C. Morris	21
7	Fluorescent biosensors for high throughput screening of protein kinase inhibitors 2013 ·Biotechnology Journal ·Camille Prével, Morgan Pellerano, Thi Nhu Ngoc Van, May C. Morris	27
8	Fluorescent Sensors of Protein Kinases 2012 ·Progress in molecular biology and translational science ·Thi Nhu Ngoc Van, May C. Morris	35
9	PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells 2010 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Laëtitia Kurzawa, Morgan Pellerano, May C. Morris	67
10	Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics breakdown → 2009 ·British Journal of Pharmacology ·F. Heitz, May C. Morris, Gilles Divita	713
11	Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy 2007 ·Advanced Drug Delivery Reviews ·Sébastien Deshayes, May C. Morris, F. Heitz, Gilles Divita	157
12	A non-covalent peptide-based carrier for in vivo delivery of DNA mimics 2007 ·Nucleic Acids Research ·May C. Morris, (unknown), Gudrun Aldrian, M. V. Choob, (unknown), F. Heitz, Gilles Divita	98
13	Interactions of Primary Amphipathic Cell Penetrating Peptides with Model Membranes: Consequences on the Mechanisms of Intracellular Delivery of Therapeutics 2005 ·Current Pharmaceutical Design ·Sébastien Deshayes, May C. Morris, Gilles Divita, F. Heitz	22
14	Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression 2004 ·Gene Therapy ·May C. Morris, Laurent Chaloin, M. V. Choob, (unknown), F. Heitz, Gilles Divita	50
15	On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids 2004 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Sébastien Deshayes, Sabine Gerbal‐Chaloin, May C. Morris, Gudrun Aldrian, Pierre Charnet, Gilles Divita, F. Heitz	98
16	Functional cdc25C Dual-Specificity Phosphatase Is Required for S-Phase Entry in Human Cells 2003 ·Molecular Biology of the Cell ·Patric Turowski, Céline Franckhauser, May C. Morris, Philippe Vaglio, Anne Fernandez, Ned Lamb	67
17	Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast 2003 ·Nature ·May C. Morris, Peter Kaiser, Stanislav G. Rudyak, (unknown), Mark H. Watson, Steven I. Reed	105
18	Characterization of the interactions between human cdc25c, cdks, cyclins and cdk-cyclin complexes 1 1Edited by J. Karn 1999 ·Journal of Molecular Biology ·May C. Morris, Gilles Divita	11
19	Effects of Phosphorylation of Threonine 160 on Cyclin-dependent Kinase 2 Structure and Activity 1999 ·Journal of Biological Chemistry ·Nicholas R. Brown, M.E.M. Noble, Alison M. Lawrie, May C. Morris, Paul Tunnah, Gilles Divita, L.N. Johnson, Jane Endicott	187
20	A new peptide vector for efficient delivery of oligonucleotides into mammalian cells 1997 ·Nucleic Acids Research ·May C. Morris	411

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact